Units: 4
Quarter: Winter
Location: 205
Monday and Thursday
Time: 2 - 3:30 PM
The course covers the molecular and structural basis ofneurodegenerative diseases. Emphasis is placed on both the underlying mechanisms and potential avenues for therapeutic intervention.
Course goals are to develop skills in critical reading, analysis, presentation and creative hypothesis formulation using nineneurological diseases as a knowledge base (1 lecture and 1
discussion session each). Passing requirements are full attendance, participation and an oral presentation.
COURSE DIRECTOR: Nigel Calcutt
CONTACT: Nigel Calcutt at ncalcutt@ucsd.edu or 858-534-5331
| Block |
Month |
Date |
Faculty |
Subject |
| Structure and Function |
|
|
|
|
| 1. |
January |
3 |
Andrew Mizisin (Block Leader) |
Neuroanatomy/Histology |
| 2. |
January |
6 |
Joan Heller Brown |
CNS transmitters |
| 3. |
January |
10 |
Charles Stevens |
Synaptic Physiology |
| 4. |
January |
13 |
Mizisin/Brown |
DISCUSSION |
| CNS Pharmacology |
|
|
|
|
| 5. |
January |
17 |
Joan Heller Brown (Block Leader) |
Therapy of Psychiatric Diseases |
| 6. |
January |
20 |
Ron Kuczenski |
Methamphetamine |
| 7. |
January |
24 |
Stuart Lipton |
Excitotoxicity and Neuroprotective Drug Design |
| 8. |
January |
27 |
Brown/Calcutt |
STUDENT PRESENTATION I |
| Muscle and Nerve |
|
|
|
|
| 9. |
January |
31 |
Nigel Calcutt (Block Leader) |
Peripheral Neuropathy |
| 10. |
February |
3 |
Palmer Taylor |
Drug Action at the Neuromuscular Junction |
| 11. |
February |
7 |
Diane Shelton |
Muscular Dystrophies & Myasthenia Gravis |
| 12. |
February |
10 |
Calcutt/Shelton |
STUDENT PRESENTATION II |
| CNS Processing |
|
|
|
|
| 13. |
February |
14 |
Martin Marsala |
Spinal Cord Injuries and Repair by Stem Cells |
| 14. |
February |
17 |
Tony Yaksh (Block Leader) |
Neuropathic Pain |
| 15. |
February |
21 |
Tony Yaksh |
Treating Neuropathic Pain |
| 16. |
February |
24 |
Yaksh/Calcutt |
STUDENT PRESENTATION III |
| CNS Neurodegeneration |
|
|
|
|
| 17. |
February |
28 |
Eliezer Masliah |
Alzheimers Disease |
| 18. |
March |
3 |
Katerina Akassoglou |
Multiple Sclerosis |
| 19. |
March |
7 |
Christina Sigurdson |
Prion Disease |
| 20. |
March |
10 |
Brown/Muotri |
THERAPEUTIC CASE STUDIES |
| 21. |
March |
14 |
TBD |
PRESENTATION IV |
| 22. |
March |
17 |
TBD |
PRESENTATION V |
Notes:
Class mechanics and evaluation methods will be announced shortly before the course begins.